Blog: Interdisciplinary Reflections on the U.S. Executive Order on Advancing Biotechnology and the Bioeconomy
In December, GES-affiliated faculty and students participated in a roundtable discussion on the EO at the recent Society for Risk Analysis Annual Meeting, held in Washington, DC. The roundtable aimed to discuss the strengths and limitations of the recent EO on bio-innovation from interdisciplinary perspectives, highlighting aspects of biotechnology regulation and risk in particular....![Gould, Fred, et al. "Toward product-based regulation of crops: Current process-based approaches to regulation are no longer fit for purpose." Science 377, 1051 (2022). DOI: 10.1126/science.abo3034 Figure 1. We propose a strategy for evaluating crop varieties using omics technologies [adapted from (1)] to compare a new genetically engineered (GE) or non-GE variety to a set of varieties that are currently in markets.](https://ges.research.ncsu.edu/wp-content/uploads/2022/09/1-EO-Gould-150x150.jpg)
Publications Relevant to the new Executive Order on Biotechnology
On September 12, 2022, President Joe Biden signed Executive Order 14081, Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy, intended to “accelerate biotechnology innovation and grow America’s bioeconomy across multiple...Continue reading "Publications Relevant to the new Executive Order on Biotechnology"